You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 87 No. 2, FEBRUARY 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Progress Volume: Modern Developments in Therapeutics and Methods of Treatment, to Accompany "An Integrated Practice of Medicine."

By Harold Thomas Hyman, M.D. Price, $10. Pp. 867. W. B. Saunders Company, 218 W. Washington Sq., Philadelphia 5; 7 Grape St., Shaftesbury Ave., London, W.C. 2, 1950.

AMA Arch Intern Med. 1951;87(2):324-325.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This progress volume is full of useful information. Many tables summarize a large amount of material and are a good source of information when there is little time to search elsewhere. In the first part of the volume the various antigens used in diagnosis are listed, and one learns where one can obtain such skin testing agents as coccidioidin, which as yet is commercially unavailable. The therapeutic usefulness of aureomycin, chloramphenicol (chloromycetin®) and terramycin is well summarized, but, of course, individual observations do differ. The author places chloramphenicol ahead of a combination of streptomycin and sulfonamides in the treatment of Bacillus pyocyaneus infections.

In addition, there is a large quantity of useful laboratory material relative to the employment of various therapeutic agents. For example, the various methods of determining the coagulation time and the prothrombin time are outlined in a discussion on bishydroxycoumarin (dicumarol®) and heparin therapy.

Such . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.